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Diagnosis of disseminated candidiasis (DC) is difficult, as there
are no distinctive clinical signs indicative of candida infection
[1]. Serologic diagnostic tests for antibody detection have been
used for laboratory diagnosis [2–4]. Assays to detect antibodies
to Candida albicans antigens expressed specifically on the germ
tube cell wall surface (CAGT antibodies) may be of greater
value, since the mycelial phase is virtually always found during
tissue invasion [5]. In 1986, Ponton and Jones identified a
polysaccharide-rich high-molecular-weight (235–250-kDa)
antigen on the surface of germ tubes that was absent in
yeast-phase C. albicans [6,7]. The simplified adsorption method
for CAGT antibody detection has been shown to be useful in
the serodiagnosis of invasive candidiasis [8].
The aim of this study was to evaluate CAGT antibodies in
intravenous heroin addicts with DC.
From January 1993 to November 1995, 87 serum samples
were drawn from 67 patients in the Infectious Diseases Unit at
the Reina Sofı´a University Hospital (Co´rdoba, Spain). Sera
were aliquoted and frozen to 708C until use. Group I con-
sisted of 33 intravenous brown heroin addicts with systemic
candidiasis, all but two co-infected with HIV (31 males, 2
females, mean age 28.7 (range 18–47)). The mean CD4þ cell
count was 273 (range 4–648) in the HIV-infected patients, none
of whom were undergoing antiretroviral therapy. A diagnosis of
DC was made when an intravenous brown heroin addict
displayed the characteristic ocular symptoms (chorioretinitis
or endophthalmitis), cutaneous lesions (deep-seated nodules
on the scalp and pustules in hairy zones) or costochondral
tumors. A 21-day course of treatment with amphotericin B was
started. CAGT antibody levels were monitored regularly in 12
patients throughout treatment. Group II consisted of 34 patients
(intravenous heroin addicts with HIV) having an infectious
disease other than candidiasis (26 males, 8 females, mean age
33.3 (range 12–69)). Groups I and II are thus comparable in
terms of HIV disease status. Group III consisted of 60 healthy
blood donors (38 males, 22 females, aged 20–50).
Antibody detection was performed in adsorbed sera by
indirect immunofluorescence (IF) assay, following the proce-
dure outlined by Ponto´n et al [8,9]. C. albicans serotype A
(NCPF 3153) was grown as germ tubes or blastospores in
medium 199 (Sigma, St Louis, Mo, USA). Washed germ tubes
and blastospores were used in the preparation of IF slides.
Heat-killed blastospores of the same strain were used in serum
adsorption. The adsorbing suspension was prepared by heating
the blastospores at 60 8C for 2 h. After three washes in saline,
organisms were counted in a hemacytometer and suspended
at 1 1010 cells/mL. Each serum specimen (25 mL) was
adsorbed once with 375mL of suspension. Adsorption was
performed under rotation by placing the tubes on a turntable
which inverted the tubes repeatedly for 2 h at room tempera-
ture.Supernatants (finaldilution,1 : 16)wereadjustedto1 : 20 and
used for antibody detection. Samples were diluted to endpoint.
Microorganisms were fixed on 12-well Teflon slides. Ten-
milliliter aliquots of diluted sera were applied to each well
and incubated at 37 8C for 30 min. Slides were washed twice
withphosphate-bufferedsaline(PBS)andthendried.Fluorescein-
conjugated antihuman immunoglobulin (Wellcome Reagents
Ltd, Beckenham, UK) was added to each well, and plates were
incubated at 37 8C for 30 min. Slides were again washed twice
with PBS and examined with a microscope equipped to detect
reflected fluorescence (Nikon Fluophote). Slides were inter-
preted by one person, who was blind to patient groups.
Samples were obtained whenever the Microbiology Labora-
tory was notified of a clinical suspicion of candidiasis. Sera were
stored and tested once a week. At lease two serum samples were
collected per patient. Samples from the same patient were tested
in parallel.
In group I, ocular lesions (chorioretinitis or endophthalmitis)
were present in all 33 patients. Ocular involvement alone was
disclosed in 16 patients. C. albicans grew in the blood cultures of
14 patients and C. krusei in those of two patients. C. albicans and
C. krusei were detected in the same blood samples of one other
patient. Candida spp. were not observed in cultures of respira-
tory samples obtained by bronchoscopy. In addition to DC,
three patients suffered from pulmonary tuberculosis and one
other patient developed Pneumocystis carinii pneumonia. CAGT
antibodies were detected in 45 of the 47 sera (95.74%) from 32
of the 33 patients in group I (96.9%). Titers ranged from 1/20 to
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1/1280, but lay mostly between 1/20 and 1/40. The only
patient negative for CAGTantibodies was positive for C. krusei,
which would account for the negative result.
In group II, the diseases other than DC were: 10 pulmonary
tuberculosis; five invasive aspergillosis; five systemic cryptococ-
cosis; seven CMV diseases (one pneumonia, one retinitis, two
esophagitis, three disseminated diseases in two bone marrow
patients and one heart transplant patient); three Pseudomonas
aeruginosa pneumonia; one acute syphilis; one brain toxoplas-
mosis; and two methicillin-sensitive Staphylococcus aureus right-
sided endocarditis. No CAGT antibodies were detected in
groups II or III (Table 1).
Antigens specific to germ tubes or to the mycelial phase of C.
albicans were first described over 10 years ago, though none of
these have been purified and evaluated for antibody detection
[9–12]. Later, an attempt was made to diagnose DC by detec-
tion of specific antibodies to mycelial-phase cell wall antigens
[13]; however, false-positive reactions occurred, as the antigerm
tube antiserum had not been absorbed with blastospores, and
antigens not specific to the germ tubes also prompted reactions.
This paper describes detection of CAGT antibodies in 33
brown heroin addicts with DC. All but two were infected with
HIV. The assay yielded 96% sensitivity, 100% specificity, a
positive predictive value of 100%, and a negative predictive
value of 98%. These results are better than those reported in
other serologic tests for diagnosis of DC.
In heroin addicts with systemic candidiasis, the sensitivity and
specificity of indirect hemagglutination, indirect IF (detecting
antiblastospore antibodies) and counter-immunoelectrophor-
esis were 97%, 91% and 58%, and 60%, 50% and 96%, respec-
tively [14].
Blood cultures were positive to C. albicans in 14 patients, C.
krusei in two patients and mixed C. albicans and C. krusei in one
patient. Positive anti-C. albicans germ tube antibody titers were
obtained in all of these. Mixed infection with C. albicans and C.
krusei, not detected in the two patients with C. krusei in blood
cultures, could not be ruled out as an initial possibility. How-
ever, detection of CAGTantibodies in C. krusei candidemia has
also been previously reported [5,15].
The antibody test does not usually distinguish between active
and past infections. In the present study, 12 patients with DC
were monitored for CAGT antibody titers during treatment. A
final assay was performed 90 days after treatment in seven
patients. In all cases, titers gradually fell, reaching negative
values at 90 days. However, given that serologic test endpoints
can vary by1 dilution within experimental error, there appear
to be only five patients for whom the change in titers may be
relevant. Further research is required in order to fully evaluate
the role of CAGT antibody detection in monitoring DC
therapy.
In conclusion, a positive serum CAGTantibody finding may
be of value as an additional tool in the diagnosis of invasive
candidiasis for C. albicans in heroin addicts.
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